We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+2.2%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$4.12B
AUM Growth
-$54.3M
Cap. Flow
+$518K
Cap. Flow %
0.01%
Top 10 Hldgs %
6.44%
Holding
1,475
New
99
Increased
592
Reduced
300
Closed
114

Sector Composition

Rank Sector Weight
1 Financials 25.32%
2 Consumer Discretionary 11.88%
3 Industrials 11.76%
4 Technology 10.68%
5 Energy 10.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KPLT icon
1176
Katapult Holdings
KPLT
$33.2M
$127K ﹤0.01%
12,416
DFLI icon
1177
Dragonfly Energy
DFLI
$18.9M
$127K ﹤0.01%
916
+556
+154% +$97.7K
BZFD icon
1178
BuzzFeed
BZFD
$96.7M
$127K ﹤0.01%
83,000
TXMD icon
1179
TherapeuticsMD
TXMD
$24M
$127K ﹤0.01%
42,000
KLR
1180
DELISTED
Kaleyra, Inc.
KLR
$126K ﹤0.01%
17,400
-50,000
-74% -$343K
MGYR icon
1181
Magyar Bancorp
MGYR
$123M
$125K ﹤0.01%
12,579
LGL icon
1182
LGL Group
LGL
$46.5M
$125K ﹤0.01%
29,200
KULR icon
1183
KULR Technology Group
KULR
$135M
$125K ﹤0.01%
43,588
SIEN
1184
DELISTED
Sientra, Inc.
SIEN
$125K ﹤0.01%
44,900
+24,700
+122% +$76K
DMRA
1185
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.84B
$125K ﹤0.01%
6,924
DNMR
1186
DELISTED
Danimer Scientific, Inc.
DNMR
$124K ﹤0.01%
1,500
-1,625
-52% -$147K
CVGI icon
1187
Commercial Vehicle Group
CVGI
$147M
$124K ﹤0.01%
16,000
CADL icon
1188
Candel Therapeutics
CADL
$776M
$123K ﹤0.01%
132,595
NAUT icon
1189
Nautilus Biotechnolgy
NAUT
$115M
$123K ﹤0.01%
38,800
NXTC icon
1190
NextCure
NXTC
$26.7M
$122K ﹤0.01%
7,883
TBIO
1191
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
$122K ﹤0.01%
6,500
VNRX icon
1192
VolitionRx Ltd
VNRX
$9.34M
$121K ﹤0.01%
8,805
INSG icon
1193
Inseego
INSG
$90.5M
$121K ﹤0.01%
28,700
UBX
1194
DELISTED
Unity Biotechnology
UBX
$120K ﹤0.01%
50,000
STIM icon
1195
Neuronetics
STIM
$166M
$119K ﹤0.01%
88,005
+25,000
+40% +$43.8K
CONN
1196
DELISTED
Conn's Inc.
CONN
$119K ﹤0.01%
30,000
-20,000
-40% -$83K
SCTL
1197
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$117K ﹤0.01%
249,600
SGRP
1198
DELISTED
SPAR Group
SGRP
$116K ﹤0.01%
120,200
BOLT icon
1199
Bolt Biotherapeutics
BOLT
$7.78M
$116K ﹤0.01%
5,560
+500
+10% +$12.2K
PRLD icon
1200
Prelude Therapeutics
PRLD
$390M
$114K ﹤0.01%
36,949

Similar funds

Bridgeway Capital Management's Q3 2023 Portfolio in Review

As of Q3 2023, Bridgeway Capital Management held 1,475 positions worth $4.12B, down 1.3% from $4.18B the previous quarter. Its ten largest holdings account for 6.4% of the portfolio.

Bridgeway Capital Management's Q3 2023 filing shows 99 new, 592 increased, 300 reduced and 114 closed positions. Its largest new stake was Vir Biotechnology: 1,345,635 shares worth $12.6M. The largest sale was Boise Cascade, an estimated $17.7M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Bridgeway Capital Management's largest Q3 2023 buy was Vir Biotechnology: 1,345,635 shares worth $12.6M.
  • Bridgeway Capital Management added most to Oracle in Q3 2023, an estimated $12.4M increase.
  • Bridgeway Capital Management's biggest Q3 2023 reduction was Boise Cascade, cutting an estimated $17.7M.
  • Bridgeway Capital Management fully exited Treehouse Foods in Q3 2023, selling an estimated $11.5M.
  • Bridgeway Capital Management's ten largest holdings make up 6.4% of its $4.12B portfolio in Q3 2023.
  • Bridgeway Capital Management opened 99 new positions and closed 114 in Q3 2023.
  • Bridgeway Capital Management's portfolio value fell 1.3% quarter-over-quarter to $4.12B.

Based on Bridgeway Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.